American College of Cardiology Foundation | Journal of the American College of Cardiology | 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic CardiomyopathyA Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the American Association for Thoracic Surgery, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons

Hypertrophic Cardiomyopathy, Genetics & Sudden Death

A genetic history exciting, and tragic, Stacey Burling, The Inquirer, Feb16

ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy

The landscape of genetic variation in dilated cardiomyopathy as surveyed by clinical DNA sequencing. 
Trevor J. Pugh et al. Genetics in Medicine, Feb 7

The MOGE(S) classification for a phenotype-genotype nomenclature of cardiomyopathy: endorsed by the World Heart Federation 
Arbustini E, et al. J Am Coll Cardiol 2013 Dec;62(22):2046-72

Genetic screening can protect relatives after sudden death, by Dr Philippa Brice, PHG Foundation, Jan 21

Gene Reviews: Hypertrophic Cardiomyopathy Overview. Gene Reviews, by Allison L Cirino  and Carolyn Ho (2014)

Clinical utility gene card for: hypertrophic cardiomyopathy (type 1–14)
Yigal M Pinto, et al. Eur J Human Genetics (2011)

American College of Cardiology Foundation | Journal of the American College of Cardiology | 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic CardiomyopathyA Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the American Association for Thoracic Surgery, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons

Practice Guideline | December 2011

2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic CardiomyopathyA Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the American Association for Thoracic Surgery, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons

Bernard J. Gersh, MB, ChB, DPhil, FACC, FAHA; Barry J. Maron, MD, FACC; Robert O. Bonow, MD, MACC, FAHA; Joseph A. Dearani, MD, FACC; Michael A. Fifer, MD, FACC, FAHA; Mark S. Link, MD, FACC, FHRS; Srihari S. Naidu, MD, FACC, FSCAI; Rick A. Nishimura, MD, FACC, FAHA; Steve R. Ommen, MD, FACC, FAHA; Harry Rakowski, MD, FACC, FASE; Christine E. Seidman, MD, FAHA; Jeffrey A. Towbin, MD, FACC, FAHA; James E. Udelson, MD, FACC, FASNC; Clyde W. Yancy, MD, FACC, FAHA

[+] Author Information

J Am Coll Cardiol. 2011;58(25):e212-e260. doi:10.1016/j.jacc.2011.06.011

Article

Figures

Tables

References

Supplemental Materials

text A A A

• 
• 
• 
• 
• 

Figures in this Article

ACCF/AHA Task Force Members

Alice K. Jacobs, MD, FACC, FAHA, Chair, 2009–2011; Sidney C. Smith, Jr, MD, FACC, FAHA, Immediate Past Chair, 2006–2008¶¶

¶¶ Former Task Force member during this writing effort.

; Jeffrey L. Anderson, MD, FACC, FAHA, Chair-Elect; Nancy M. Albert, PhD, CCNS, CCRN, FAHA; Christopher E. Buller, MD, FACC¶¶; Mark A. Creager, MD, FACC, FAHA; Steven M. Ettinger, MD, FACC; Robert A. Guyton, MD, FACC; Jonathan L. Halperin, MD, FACC, FAHA; Judith S. Hochman, MD, FACC, FAHA; Harlan M. Krumholz, MD, FACC, FAHA¶¶; Frederick G. Kushner, MD, FACC, FAHA; Rick A. Nishimura, MD, FACC, FAHA¶¶; E. Magnus Ohman, MD, FACC; Richard L. Page, MD, FACC, FAHA¶¶; William G. Stevenson, MD, FACC, FAHA; Lynn G. Tarkington, RN¶¶; Clyde W. Yancy, MD, FACC, FAHA